Heska Corp logo

Heska Corp (HSKA)

Market Closed
12 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
119. 99
0
0%
$
1.31B Market Cap
- P/E Ratio
0.3% Div Yield
330,887 Volume
- Eps
$ 119.99
Previous Close
Add Transaction
Day Range
119.99 119.99
Year Range
57.83 120.03
Want to track HSKA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HSKA closed Monday higher at $119.99, an increase of 0% from Friday's close, completing a monthly increase of 0% or $119.99. Over the past 12 months, HSKA stock gained 0%.
HSKA pays dividends to its shareholders, with the most recent payment made on Oct 10, 2012. The next estimated payment will be in 10 Jan 2013 on Jan 10, 2013 for a total of $0.1.
Heska Corp has completed 1 stock splits, with the recent split occurring on Dec 30, 2010.
The company's stock is traded on one exchange.

HSKA Chart

People also search for

Viridian Therapeutics Inc.
$ 22.97
-0.3903%
Astrana Health Inc.
$ 34.48
-7.9797%
Ethos Technologies Inc.
$ 33.45
+3.1452%
Forte Biosciences, Inc.
$ 76.87
+0.0651%
MoonLake Immunotherapeutics
$ 16.59
-4.2701%

Heska Corp (HSKA) FAQ

What is the stock price today?

The current price is $119.99.

On which exchange is it traded?

Heska Corp is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is HSKA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.3%.

What is its market cap?

As of today, the market cap is 1.31B.

Has Heska Corp ever had a stock split?

Heska Corp had 1 splits and the recent split was on Dec 30, 2010.

Heska Corp Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Kevin S. Wilson CEO
NASDAQ (CM) Exchange
42805E306 CUSIP
US Country
808 Employees
26 Sep 2012 Last Dividend
30 Dec 2010 Last Split
- IPO Date

Overview

Heska Corporation is a dedicated provider of specialized diagnostic and animal health products primarily targeting the canine and feline veterinary care markets. The company operates across several countries, including the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. Founded in 1988 as Paravax, Inc. and rebranded in 1995, Heska has established itself as a leader in veterinary diagnostics and treatment solutions. The headquarters of Heska Corporation is located in Loveland, Colorado, where it develops and distributes a diverse range of innovative products for veterinarians and animal health professionals.

Products and Services

  • Veterinary Chemistry Analyzers:

    Heska offers a variety of advanced veterinary chemistry analyzers including Element DC, DCX, and DC5x series. These systems are specifically designed for blood chemistry and electrolyte analysis, helping veterinarians to obtain vital health information of their canine and feline patients.

  • Hematology Analyzers:

    The Element HT5 and scil Vet abc Plus analyzers cater to hematological assessments, measuring essential parameters such as blood cell and platelet counts, as well as hemoglobin levels, thus assisting in comprehensive health evaluations.

  • Point-of-Care Analyzers:

    Heska provides Element POC analyzers, which facilitate rapid blood gas and electrolyte testing needed for prompt diagnosis and treatment, as well as Element i immunodiagnostic analyzers for detecting various conditions.

  • Coagulation Analyzers:

    The Element COAG and Element AIM veterinary analyzers are engineered for coagulation studies, offering veterinarians precise insights into their patients' blood clotting abilities.

  • Imaging and Clinical Solutions:

    Heska’s imaging solutions include HeskaView Telecytology, which automates microscopic slide scanning for clinical use, along with advanced IV infusion pumps, ensuring efficient treatment delivery. Additionally, digital radiography hardware, mobile units, sophisticated ultrasound systems, and Cloudbank for web-based image storage are part of their offerings.

  • Point-of-Care Products:

    The company produces rapid in-clinic products designed for the detection of antigens and antibodies related to infectious and parasitic diseases, offering veterinarians timely results to enhance patient care.

  • Therapeutic Solutions:

    Heska specializes in therapeutic products such as Tri-Heart Plus chewable tablets for the effective treatment of canine heartworm as well as other parasitic infections, ensuring the health and well-being of pets.

  • Allergy Management:

    With a focus on allergy management, Heska provides ALLERCEPT definitive allergen panels that assist in the diagnosis of allergies, alongside personalized therapy shots or drops tailored to each animal’s needs.

  • Bovine Health Vaccines:

    The company develops a comprehensive range of vaccines aimed at improving bovine health, reflecting its commitment to the broader spectrum of animal health.

  • Biological and Pharmaceutical Products:

    Heska supplies an array of biological and pharmaceutical products to various animal health companies while also providing turnkey services that include research, licensing, production, labeling, packaging, validation support, and distribution.

These products are effectively distributed to veterinarians through a combination of direct telephone sales, third-party distributors, trade shows, print advertisements, and strategic partnerships, ensuring accessibility to cutting-edge veterinary care solutions.

Contact Information

Address: 3760 Rocky Mountain Avenue
Phone: 970 493 7272